Missed opportunities in HCV care: Trends in late diagnosis and treatment.

ABSTRACT:

Background & aims

Timely HCV care is essential to prevent liver disease progression. The aim of this study was to evaluate trends in late HCV diagnosis and treatment in people diagnosed with end-stage liver disease (ESLD) in New South Wales (NSW), Australia.

Methods

HCV notifications in NSW, Australia (1995-2022) were linked to hospital admissions (2010-2021) and treatment records (2002-2022). Descriptive analyses and logistic regression were used to examine trends and factors associated with late diagnosis and missed treatment opportunities. Late diagnosis and treatment were defined as the absence of HCV notification and treatment within 2 years prior to or following the first hospitalisation for ESLD.

Results

Among 4,419 people with an HCV notification and ESLD diag

SUBMITTER: Tillakeratne S 

PROVIDER: S-EPMC12355104 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature